Clinical trial
Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant…
NCT00087061 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00087061 |
|---|---|
| Title | Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma |
| Official title | Oral ST1481 in Adults With Malignant Glioma: A Phase I-II Clinical Trial |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | gimatecan |
| Start date | May 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Jul 12, 2004 |
| Last update posted | Jul 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: